Bayer Cropscience Peer Comparison

NSE: BAYERCROP | BSE: 506285

₹4,048.70

₹-19.20 (-0.47%)

As on 28-Aug-2026IST

Market cap

₹18,202 Cr

Revenue (TTM)

₹5,595 Cr

P/E Ratio

24.9

P/B Ratio

5.5

Div. Yield

3.7 %

Edit

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Market cap (₹ Cr)	18,202	25,848	7,072	4,350	4,081
Revenue (₹ Cr)	5,595	3,245	5,357	1,953	2,962
Net Profit (₹ Cr)	732.10	579.39	626.21	268.04	214.00
Net Margin (%)	12.71	17.04	11.46	13.42	7.12
RoE (%)	24.05	17.35	21.55	16.62	13.45
Price to Earnings	24.86	44.61	11.30	16.23	19.07
Price-To-Book	5.54	7.17	2.19	2.64	1.88

Income Statement (₹ Cr)

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Operating Revenue	5,675.00	3,238.32	5,267.59	2,019.79	2,896.65
Total Income	5,773.60	3,424.76	5,409.82	2,062.80	2,940.10
Total Expenditure	4,804.90	2,606.56	4,208.65	1,616.31	2,535.02
EBITDA	870.10	631.76	1,058.94	403.48	361.63
Depreciation	94.00	66.12	324.51	64.22	117.13
EBIT	776.10	565.64	734.43	339.26	244.50
Interest	19.80	8.44	21.16	3.71	11.42
Other Income	98.60	186.44	142.24	43.01	43.45
Exceptional Items	--	-16.08	--	--	-26.23
Profit before Tax	854.90	727.56	855.51	378.56	250.30
Provision for Tax	165.70	184.59	174.51	91.33	66.42
Profit after Tax	689.20	542.98	680.99	287.23	183.88

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Shareholder's Funds	2,965.70	3,389.67	3,136.49	1,681.88	2,042.97
Minority Interest	--	4.11	0.55	--	--
Non-Current Liabilities	3,107.80	110.17	235.57	49.56	619.84
Current Liabilities	2,947.10	969.81	2,517.61	370.59	1,580.13
Total Liabilities	9,033.00	4,473.76	5,890.22	2,102.02	4,248.66

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Non-Current Assets	3,722.70	1,133.61	1,320.70	584.68	1,577.96
Current Assets	5,297.90	3,340.15	4,569.51	1,517.34	2,663.69
Total Assets	9,033.00	4,473.76	5,890.22	2,102.02	4,248.66
Total Debt*	0.00	1.50	0.00	0.90	6.90
Net Current Assets	2,350.80	2,370.34	2,051.90	1,146.75	1,083.56
Contingent Liabilities	765.30	60.07	17.55	187.63	274.02

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Cash From Operating Activities	1,078.50	445.51	655.69	196.20	172.11
Cash Flow from Investing Activities	72.50	-331.95	-513.07	-118.05	-94.88
Cash from Financing Activities	-623.80	-82.88	-118.28	-59.79	-66.16
Net Cash Inflow / Outflow	527.20	30.68	24.34	18.36	11.07

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
ROCE (%)	30.08	23.39	31.10	24.44	13.23
ROE (%)	23.70	17.26	24.16	18.62	9.32
ROA (%)	7.91	12.87	12.54	14.72	4.53
EBIT Margin (%)	17.07	25.27	22.80	22.11	13.98
Net Margin (%)	11.94	15.85	12.59	13.92	6.25
Cash Profit Margin (%)	11.69	16.95	18.03	16.17	8.25

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Revenue Growth (%)	3.68	2.85	21.94	-0.75	8.78
EBIT Growth (%)	19.70	8.68	78.08	-1.37	26.67
Net Profit Growth (%)	21.34	7.21	123.70	-3.28	46.95
EPS Growth (%)	21.34	7.41	123.69	-3.28	46.95
Book Value Growth (%)	4.05	16.84	25.43	19.90	7.28

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Price / Earnings	30.30	33.53	11.52	14.10	23.03
Price / Book Value	7.04	5.37	2.50	2.41	2.07
Dividend Yield (%)	3.22	0.36	1.72	0.22	1.38
EV/EBITDA	20.09	22.10	6.35	9.03	10.36
Market Cap (₹ Cr)	20,885.70	18,203.86	7,846.59	4,048.67	4,235.19

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	--	--	0.00	0.00
Current Ratio	1.80	3.44	1.82	4.09	1.69
Quick Ratio	1.07	2.65	1.37	2.70	1.08
Interest Coverage	44.18	87.21	41.43	103.07	22.92

	Bayer Cropscience	Sumitomo Chemical	Sharda Cropchem	Dhanuka Agritech	Rallis India
Debtors to sales (%)	19.66	22.72	45.36	21.82	21.25
Asset Turnover	0.77	0.85	1.03	1.11	0.90
Receivable days	56.33	77.14	142.20	75.54	57.86
Inventory Days	122.54	74.64	68.45	76.86	85.52
Payable days	131.57	95.86	151.79	55.32	126.20
Cash Conversion Cycle	47.30	55.92	58.86	97.08	17.18

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.